Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest ExpensesInterest Income - Debt SecuritiesInterest Income - DepositsInterest Income - NetInterest Income - TotalInterest income - LoansInvestment Banking IncomeInvestment Gain (Loss)Net Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesProfit After TaxProvisionsResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Chemung Financial (CHMG) EBITDA (2016 - 2025)

Chemung Financial (CHMG) has disclosed EBITDA for 10 consecutive years, with $21.8 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 5.31% to $21.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67.3 million through Dec 2025, down 21.04% year-over-year, with the annual reading at $67.3 million for FY2025, 21.04% down from the prior year.
  • EBITDA for Q4 2025 was $21.8 million at Chemung Financial, up from $21.7 million in the prior quarter.
  • The five-year high for EBITDA was $22.6 million in Q1 2024, with the low at -$15.8 million in Q2 2023.
  • Average EBITDA over 5 years is $2.4 million, with a median of -$4.4 million recorded in 2021.
  • The sharpest move saw EBITDA soared 255.79% in 2024, then plummeted 80.92% in 2025.
  • Over 5 years, EBITDA stood at -$15.0 million in 2021, then decreased by 0.6% to -$15.1 million in 2022, then soared by 214.42% to $17.3 million in 2023, then rose by 20.07% to $20.7 million in 2024, then grew by 5.31% to $21.8 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $21.8 million, $21.7 million, and $3.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.